Upcoming Webinar: How to Understand and Leverage Your Data

White Paper

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

Sales Force Effectiveness

Share on facebook
Share on twitter
Share on linkedin

Pharmaceutical commercialization is getting more challenging every day. Analytics talent is in high demand to support informed and insightful business decisions across a global landscape. Yet, despite the increasing market complexity, most commercialization leaders are facing cost reduction pressure resulting in the exploration and assignment of work to lower-cost alternatives.

In terms of analytics support, there are typically two resource plans to choose from: Plan A: Continue the analytics function with onshore support for a high quality solution Plan B: Replace the analytics function fully or partially with offshore support for cost savings.

Does either plan provide a viable solution for commercialization leaders to have efficient and cost-effective analytics support? What challenges will one run into by choosing either plan? Let’s take a closer look at what has happened in analytics groups.

Download White Paper

For Questions, Contact Us Now

Related insights

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

KMK Welcomes Oncology Market Research Veteran Lisa Logan

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

KMK President Michael Karbachinskiy Weighs in on the use of AI and Machine Learning in Pharmaceutical Sales

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma

Allergan and Bausch Health Identified as the Top Companies Driving Therapeutic Innovation in IBS

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma